DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Allweiss L, Dettmer C, Volz T. et al.
PS-162 – Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combinationwith Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial.
Journal Of Hepatology 2018;
68: S90
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.